Production (Stage)
EyePoint Pharmaceuticals, Inc.
EYPT
$9.03
$0.171.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.30% | 12.04% | 86.60% | 96.62% | 144.40% |
| Total Receivables | -85.34% | -24.60% | -21.74% | -87.45% | -71.07% |
| Inventory | -49.99% | -40.99% | -38.67% | -13.82% | 4.57% |
| Prepaid Expenses | -49.85% | 0.57% | 20.26% | -8.53% | 5.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.53% | 39.25% | 136.43% | -- | -- |
| Total Current Assets | 2.92% | 11.17% | 78.84% | 76.48% | 117.52% |
|
|
|||||
| Total Current Assets | 2.92% | 11.17% | 78.84% | 76.48% | 117.52% |
| Net Property, Plant & Equipment | 159.52% | 185.10% | 206.23% | 247.78% | 35.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3,918.00% | 3,888.00% | 1,614.67% | 0.00% | 0.00% |
| Total Assets | 10.12% | 17.82% | 88.02% | 84.59% | 112.98% |
|
|
|||||
| Total Accounts Payable | 131.84% | 80.21% | -23.35% | 33.40% | -25.08% |
| Total Accrued Expenses | 18.47% | 7.13% | 4.92% | -12.96% | 59.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 61.02% | 121.49% | 12.29% | 16.49% | 45.62% |
| Total Finance Division Other Current Liabilities | -86.22% | -54.04% | -34.10% | -20.32% | 1,723.11% |
| Total Other Current Liabilities | -86.22% | -54.04% | -34.10% | -20.32% | 1,723.11% |
| Total Current Liabilities | -33.40% | -22.47% | -23.64% | -9.89% | 129.72% |
|
|
|||||
| Total Current Liabilities | -33.40% | -22.47% | -23.64% | -9.89% | 129.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 382.57% | 345.54% | 322.80% | 306.31% | -19.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.54% | -46.56% | -64.54% | -73.47% | -12.70% |
| Total Liabilities | -19.10% | -7.76% | -18.97% | -18.96% | 4.08% |
|
|
|||||
| Common Stock & APIC | 19.12% | 19.94% | 33.51% | 33.41% | 32.53% |
| Retained Earnings | -19.03% | -17.63% | -14.23% | -12.14% | -11.40% |
| Treasury Stock & Other | 10.41% | 18.98% | 39.24% | -5.94% | -0.83% |
| Total Common Equity | 19.39% | 26.35% | 273.13% | 298.70% | 218.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.39% | 26.35% | 273.13% | 298.70% | 218.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.39% | 26.35% | 273.13% | 298.70% | 218.83% |
|
|
|||||